switching patients' meds when Namenda (memantine) tabs are discontinued this August

Questions will come up about switching patients' meds when Namenda (memantine) tabs are discontinued this August.

The manufacturer will stop selling Namenda tabs...and will focus on once-daily Namenda XR instead.

When needed, suggest switching patients on Namenda 10 mg BID to Namenda XR 28 mg once a day. Both cost about $300/month...and they're likely to have similar tolerability and efficacy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote